XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.3
STOCKHOLDERS EQUITY
 9 Months Ended
Sep. 30, 2025
Stockholders Equity [Abstract]  
STOCKHOLDERS EQUITY

NOTE 12 – STOCKHOLDERS’ EQUITY

Increase of Authorized Omega Common Stock

On June 6, 2025, Omega amended its charter to increase the number of authorized shares of Omega common stock from 350.0 million to 700.0 million.

Stock Repurchase Program

During the three and nine months ended September 30, 2025 and 2024, we did not repurchase any shares of our outstanding common stock under the $500.0 Million Stock Repurchase Program, which expired in March 2025.

Dividends

The following is a summary of our declared cash dividends on common stock:

​

​

​

​

​

​

Record Date

    

Payment Date

    

Dividend per Common Share

February 10, 2025

​

February 18, 2025

​

$

0.67

May 5, 2025

​

May 15, 2025

​

​

0.67

August 4, 2025

​

August 15, 2025

​

​

0.67

November 3, 2025

​

November 17, 2025

​

​

0.67

​

Dividend Reinvestment and Common Stock Purchase Plan

The following is a summary of the shares issued under the Dividend Reinvestment and Common Stock Purchase Plan for the three and nine months ended September 30, 2025 and 2024 (in thousands):

​

​

​

​

​

​

​

Period Ended

Shares issued

​

Gross Proceeds

Three Months Ended

September 30, 2024

2,575

​

$

90,469

Three Months Ended

September 30, 2025

2,116

​

​

80,556

Nine Months Ended

September 30, 2024

3,017

​

​

104,366

Nine Months Ended

September 30, 2025

8,771

​

​

330,749

​

At-The-Market Offering Programs

The following is a summary of the shares issued under our former $1.0 billion 2021 At-The-Market Offering Program and our current $1.25 billion 2024 At-The-Market Offering Program (collectively, the “ATM Program”) for the three and nine months ended September 30, 2025 and 2024 (in thousands except average price per share):

​

​

​

​

​

​

​

​

​

​

​

​

Average Net Price

​

​

​

​

​

Period Ended

Shares issued

Per Share(1)

Gross Proceeds

Net Proceeds

Three Months Ended

September 30, 2024

11,630

$

37.45

$

439,685

$

435,501

Three Months Ended

September 30, 2025

208

​

40.02

​

8,566

​

8,336

Nine Months Ended

September 30, 2024

19,883

​

35.05

​

703,900

​

696,993

Nine Months Ended

September 30, 2025

7,493

​

37.05

​

280,887

​

277,632

(1)Represents the average price per share after issuance costs.

We did not utilize the forward provisions under the ATM Program during the three and nine months ended September 30, 2025 and 2024.

Accumulated Other Comprehensive Income (Loss)

The following is a summary of our accumulated other comprehensive income (loss), net of tax as of September 30, 2025 and December 31, 2024:

​

​

​

​

​

​

​

​

September 30, 

​

December 31,

​

2025

    

2024

​

​

(in thousands)

Foreign currency translation

$

15,312

​

$

(66,110)

Derivative instruments designated as cash flow hedges

​

67,237

​

​

76,713

Derivative instruments designated as net investment hedges

 

(4,235)

​

 

11,898

Total accumulated other comprehensive income before noncontrolling interest

 

78,314

​

 

22,501

Add: portion included in noncontrolling interest

 

(1,348)

​

 

230

Total accumulated other comprehensive income for Omega

$

76,966

​

$

22,731

​

​

During the three months ended September 30, 2025 and 2024, we reclassified $2.6 million and $2.7 million, respectively, of realized gains out of accumulated other comprehensive income into interest expense on our Consolidated Statements of Operations associated with our cash flow hedges. During the nine months ended September 30, 2025 and 2024, we reclassified $5.4 million and $7.9 million, respectively, of realized gains out of accumulated other comprehensive income into interest expense on our Consolidated Statements of Operations associated with our cash flow hedges.